GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Upstream Bio Inc (NAS:UPB) » Definitions » Book Value per Share

UPB (Upstream Bio) Book Value per Share : $8.77 (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Upstream Bio Book Value per Share?

Upstream Bio's book value per share for the quarter that ended in Dec. 2024 was $8.77.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

Upstream Bio's current price is $8.64. Its book value per share for the quarter that ended in Dec. 2024 was $8.77. Hence, today's PB Ratio of Upstream Bio is 0.99.

During the past 3 years, the highest P/B Ratio of Upstream Bio was 2.09. The lowest was 0.70. And the median was 0.98.


Upstream Bio Book Value per Share Historical Data

The historical data trend for Upstream Bio's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Upstream Bio Book Value per Share Chart

Upstream Bio Annual Data
Trend Dec22 Dec23 Dec24
Book Value per Share
-2.92 -2.40 8.77

Upstream Bio Quarterly Data
Dec22 Sep23 Dec23 Jun24 Sep24 Dec24
Book Value per Share Get a 7-Day Free Trial - -2.40 -2.86 -3.12 8.77

Competitive Comparison of Upstream Bio's Book Value per Share

For the Biotechnology subindustry, Upstream Bio's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Upstream Bio's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Upstream Bio's PB Ratio distribution charts can be found below:

* The bar in red indicates where Upstream Bio's PB Ratio falls into.


;
;

Upstream Bio Book Value per Share Calculation

Upstream Bio's Book Value Per Share for the fiscal year that ended in Dec. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(469.85-0.00)/53.60
=8.77

Upstream Bio's Book Value Per Share for the quarter that ended in Dec. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(469.85-0.00)/53.60
=8.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Upstream Bio  (NAS:UPB) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Upstream Bio Book Value per Share Related Terms

Thank you for viewing the detailed overview of Upstream Bio's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Upstream Bio Business Description

Traded in Other Exchanges
N/A
Address
890 Winter Street, Suite 200, Waltham, MA, USA, 02451
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases.